United States· US:62332-147_64d45e8d-158b-42f2-84aa-14fc849eaf0e
alcaftadine
A alcaftadine product containing alcaftadine, registered in United States by Alembic Pharmaceuticals Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ALCAFTADINE
- Manufacturer
- Alembic Pharmaceuticals Inc.
- Country
- United States (US)
- ATC code
- S01GX11
- ATC class
- Alcaftadine
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1162332-147-03
- ndc1162332147031 BOTTLE in 1 CARTON (62332-147-03) / 3 mL in 1 BOTTLE
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under S01GX11
Alcaftadine, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6f1f7b3c-051a-4f30-b1e2-aa4d4d11f8ce GET /v1/drugs/6f1f7b3c-051a-4f30-b1e2-aa4d4d11f8ce?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "OPHTHALMIC",
"source": "ndc",
"strength": "2.5",
"substance": "ALCAFTADINE",
"productndc": "62332-147",
"dosage_form": "SOLUTION/ DROPS",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "ANDA209290",
"marketing_category": "ANDA"
}See everything about alcaftadine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.